Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.

A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer

NCT01383863 ·Status: COMPLETED

Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer

NCT01020448 ·Status: COMPLETED ·Phase: PHASE3

AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer

NCT00519233 ·Status: COMPLETED ·Phase: PHASE1

Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy

NCT03516110 ·Status: COMPLETED

A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in Italy

NCT05759273 ·Status: COMPLETED

Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT

NCT05983198 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate

NCT05458856 ·Status: COMPLETED ·Phase: PHASE3

Impact of New Hormonotherapy Drugs in Prostatic Cancer on the Risk of Cardiovascular Events : a Pharmacoepidemiology Study Using the French Health Care Claims Database

NCT06902441 ·Status: COMPLETED

A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer

NCT03879122 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer

NCT04557059 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

NCT00021450 ·Status: COMPLETED ·Phase: PHASE3

A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan

NCT04034095 ·Status: COMPLETED

Study of Irofulven in Patients With Hormone-refractory Prostate Cancer

NCT00124566 ·Status: COMPLETED ·Phase: PHASE2

A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer

NCT00036543 ·Status: COMPLETED ·Phase: PHASE3

A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer

NCT00286806 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

An Open Label Prostate Cancer Study in Japanese Patients

NCT01351688 ·Status: COMPLETED ·Phase: PHASE1

Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer

NCT02907372 ·Status: COMPLETED ·Phase: NA

Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP

NCT03899077 ·Status: RECRUITING ·Phase: PHASE2

Investigation of Early Hormonotherapy Efficacy of Prostate Cancer

NCT00375687 ·Status: UNKNOWN ·Phase: NA

A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer

NCT01964170 ·Status: COMPLETED ·Phase: PHASE3

A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

NCT01834209 ·Status: NO_LONGER_AVAILABLE

A Study on Drug-drug Interactions in Patients Treated With Anticancer Agents for a Prostate Cancer in Real Life Setting

NCT05612841 ·Status: UNKNOWN

Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer

NCT00751790 ·Status: COMPLETED ·Phase: PHASE3

Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma Prostate

NCT01255891 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

NCT06473259 ·Status: RECRUITING